Who founded Calliotx?

Calliotx was founded by Piers Ingram, Jerome Boyd-Kirkup in 2025.

Who are Calliotx's investors?

Calliotx's investors include Novo Holdings, Omega Funds, Frazier Life Sciences, Jeito Capital, Norwest Venture Partners.

Where is Calliotx headquartered?

Calliotx is headquartered in Seattle, US.

Calliotx

Seattle, US · Founded 2025 · 20 employees on LinkedIn · 5 known investors

Find your way into Calliotx

453 people in our graph share verified history with the Calliotx team — schools, employers, funds. One of them is your warm intro.

Hannah Sealunlockedknows Jerome Boyd-Kirkup · together at University of Cambridge (overlapped)

×3knows the team · via Imperial College London

×8knows the team · via University of Cambridge

Callio Therapeutics develops next-generation dual-payload antibody-drug conjugates (ADCs) with differentiated payload and linker technologies for targeted cancer treatment. The company's lead program is a dual-payload HER2-targeted ADC designed to deliver drug combinations to tumor cells.

Biotech Medical Devices

Founders & leadership

Calliotx was founded in 2025 by Piers Ingram and Jerome Boyd-Kirkup.

Piers IngraminPresident, Co-Founder

Jerome Boyd-Kirkup inChief Scientific Officer, Co-FounderJerome Boyd-Kirkup is co-founder and Chief Scientific Officer of Calliotx, which develops antibody-drug conjugates for cancer treatment. He holds a background in molecular biology with experience spanning computational and wet lab research, and has spent nearly two decades in drug discovery and development across the UK and Asia.

Zachary HornbyChief Executive Officer

Investors · 5

Novo Holdings✓ verifiedCopenhagen · $1.1M – $54M

Omega Funds✓ verifiedBoston

Frazier Life SciencesPalo Alto

Jeito CapitalParis

Norwest Venture PartnersMenlo Park · $10M – $30M

Competitors · 1

by search overlap

Eli Lilly41 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

Companies competing with Calliotx for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Forward Financing $525 Million: VFN + ABS Deal Explainedfunderintel.com · Jul 2026

Frequently asked questions

What does Calliotx do?: Callio Therapeutics develops next-generation dual-payload antibody-drug conjugates (ADCs) with differentiated payload and linker technologies for targeted cancer treatment. The company's lead program is a dual-payload HER2-targeted ADC designed to deliver drug combinations to tumor cells.
Who founded Calliotx?: Calliotx was founded by Piers Ingram, Jerome Boyd-Kirkup in 2025.
Who are Calliotx's investors?: Calliotx's investors include Novo Holdings, Omega Funds, Frazier Life Sciences, Jeito Capital, Norwest Venture Partners.
Where is Calliotx headquartered?: Calliotx is headquartered in Seattle, US.